AbbVie Retained Earnings (Accumulated Deficit) 2010-2024 | ABBV
AbbVie retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-4.964B, a 632.05% decline year-over-year.
- AbbVie retained earnings (accumulated deficit) for 2023 were $-1B, a 120.9% decline from 2022.
- AbbVie retained earnings (accumulated deficit) for 2022 were $4.784B, a 52.99% increase from 2021.
- AbbVie retained earnings (accumulated deficit) for 2021 were $3.127B, a 196.4% increase from 2020.